Shell plc (SHEL) — Investment Tree v1
Stage 7 final essay. Bilingual companion: tree_v1_zh.md. Date: 2026-08-13 · Anchor price: $90.50/ADS (2026-08-11 close, Tier B) · Market cap ≈$255B† · 1 ADS = 2 ordinary shares (Tier A, 20-F) · Reporting currency USD · Dividend $0.3906/quarter, ~1.7% ADS yield† Archetype: disciplined capital-return major priced on war-inflated earnings — a well-run cyclical whose thesis was overtaken by a variable the thesis does not contain
SOURCE QUALITY — read this before any number below. The spine of this tree is Tier A: the FY2025 20-F filed 2026-03-12 (evidence_2026-08-01.jsonl, 24 rows / 18 load-bearing). Three things that matter are not:
- The entire Q2 2026 print (2026-07-30) — adjusted earnings $9.84B, CFFO >$21B, FCF $17.5B, net debt $41.8B, gearing 18.7%, all segment figures. Tier B, from press aggregation of a 6-K whose financial exhibits the Stage 0 fetch never captured (rows -018, -019 record this explicitly). Not cross-checked against the primary filing.
- The ARC Resources deal terms and the war/commodity data — Tier B, though the ARC figures are corroborated across four independent sources landing on identical numbers.
- Every peer multiple — Tier B, and see §VII for why they are close to uninterpretable regardless of tier.
Anything marked † is Tier C interpolation.
0. Company Fundamentals — what Shell is and how it earns
Figures FY2025 (year ended 2025-12-31) unless noted. Shell is a 20-F filer, not a 10-K filer. Primary listing SHEL.L (London); the analysis ticker is the NYSE ADS. Shell reports in USD.
What it is. Shell plc is a UK-domiciled integrated energy major — one of five Western supermajors — that explores for, produces, ships, trades, refines and markets oil, natural gas and LNG at global scale. It took its current legal shape in January 2022 when Royal Dutch Shell collapsed its dual A/B structure, moved from The Hague to London and dropped "Royal Dutch." Since Wael Sawan became CEO in January 2023 the strategy has been explicit and consistent: harvest and exit low-return renewables, concentrate capital on LNG and upstream, cut structural cost, return cash.
How it earns. FY2025 revenue was $266,886M, down from $284,312M (FY2024) and $316,620M (FY2023) — a three-year decline driven by commodity prices, not by lost share. Adjusted earnings were $18,528M, down 21.9% in a year and 34.4% in two.
| Segment | FY2025 adj. earnings | FY2024 | Direction |
|---|---|---|---|
| Integrated Gas (LNG liquefaction, shipping, trading) | $8,024M | $11,390M | −29.5% — largest segment, biggest decline |
| Upstream (oil & gas production) | ≈$7,400M | ≈$8,400M | −$953M on realised prices, +$0.9B on volumes |
| Marketing (mobility, lubricants, B2B) | $3,994M | $3,885M | +2.8% — third straight year of growth |
| Chemicals & Products (refining + petchem) | $1,100M | $2,900M | −65% on trading and chemicals margins |
| Renewables & Energy Solutions | $172M | −$497M | swung positive; <1% of group; being exited |
Cash-flow anatomy.
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| CFFO | $54,191M | $54,687M | $42,863M |
| Cash capex | — | — | $20,915M |
| Free cash flow | $36,457M | $39,533M | $26,052M |
| Distributions (buyback + dividend) | — | — | $22,372M |
| FCF coverage of distributions | — | — | 1.16× |
| Distributions / CFFO | — | — | 52.2% (policy band: 40-50%) |
Balance sheet. FY2025 net debt $45,687M on total debt of $75,643M; gearing 20.7% (2024: 17.7%). Then the two prints that matter: Q1 2026 net debt $52.6B / gearing 23.2%, and Q2 2026 net debt $41.8B / gearing 18.7% — $10.8B of net debt removed in ninety days, leaving gearing below where the year started.
Capital return. Buybacks of $13,900M in FY2025 retiring 6.5% of shares outstanding at an average $35.01 per ordinary share; 17 consecutive quarters of repurchases through end-2025 at a $3.5B/quarter cadence. Dividends $8,472M; DPS $1.446, growing 4%/yr. In July 2026 Shell announced $3.0B of new buybacks plus $1.232B carried over from a securities-law pause. Shares outstanding at 2025-12-31: 5,689,891,670 ordinary = ~2,845M ADS.
Cost and capex discipline. Structural savings of $5.1B cumulative by end-2025 against an original $2-3B target — delivered three years early; new target $5-7B by 2028, with $700M more in the first half of 2026. Capex guidance was lowered to $20-22B/yr for 2025-2028 from $22-25B; the 2026 guide of $24-26B includes ~$4B for ARC.
ROACE: 12.8% (FY2023) → 11.3% (FY2024) → 9.4% (FY2025). Against a WACC of roughly 8-10%†, that last number sits inside the band rather than above it. It is the most important single figure in this document and it is discussed at length in §IX.
I. One-sentence verdict
Shell is a genuinely well-run capital-return machine — gearing at 18.7%, cost targets beaten three years early, 6.5% of the share count retired in a year at prices ~28% below where it just issued stock — trading at $90.50 on earnings that a war has temporarily doubled, which makes almost every valuation comparison in the market currently meaningless; the thesis this tree was commissioned to test (that Shell has an unpriced opportunistic-M&A identity and an unpriced LNG premium) is largely dissolved by the last two months of data, leaving a moderately favourable 1.59:1 asymmetry that is not enough to own today; WATCH at 0%, with a 1-2% starter defensible only after Qatar restoration is confirmed at CP1.
II. Company snapshot
Shell sells 73 million tonnes of LNG a year — roughly a fifth of global LNG demand — operates the largest integrated LNG trading and shipping portfolio among the Western majors, sustains ~1.4 million boe/d of liquids production, runs a global retail fuels and lubricants network, and refines and trades petrochemicals principally in Europe, the US Gulf Coast and Asia. It employs the balance sheet of a AA-grade issuer and the capital-allocation policy of a mature cash-return vehicle: 40-50% of operating cash flow to shareholders, a 4%-a-year progressive dividend, and a buyback that has run for seventeen consecutive quarters.
Two things have happened since the FY2025 accounts closed. In April 2026 Shell agreed to acquire ARC Resources — Canadian Montney natural gas — for C$32.80 per share (C$8.20 cash + 0.40247 Shell ordinary), an equity value of US$13.6B and an enterprise value of US$16.4B including ~US$2.8B of assumed net debt and leases, at a 27% premium, funded 75% in stock and 25% in cash. ARC holders approved it 99.54%; it is expected to close in H2 2026.
And in late February 2026 a US-Israel war on Iran began. Brent went above $115 in March, peaked above $126 on 30 April, and sits near $89.50 in mid-August — about 24% above pre-war. The Strait of Hormuz remains disrupted. Shell's Q2 2026 adjusted earnings more than doubled year over year to $9.84B. In the same quarter, Integrated Gas production fell from 909 kboe/d to a guided 610-650 kboe/d, because Qatari LNG facilities were damaged by missile strikes — and Shell's Q3 2026 guidance assumes zero output from Qatar, with repairs running to Q1 2027.
Shell is on both sides of the same war. That is the company you are actually being asked to price.
III. The five facts that drive everything
- Gearing fell from 23.2% to 18.7% in one quarter, net debt $52.6B → $41.8B, on $17.5B of quarterly free cash flow. Shell is less levered than it was at the start of the year. ⚠️B (Tier B, and it is the fact the whole bear case was built against)
- The ARC acquisition is 75% stock and 25% cash — US$3.4B of cash against a US$16.4B enterprise value, with ~228M new ordinary shares issued at an implied ~$44.7 versus a FY2025 buyback average of $35.01. Retire low, issue high. ✅B
- Q2 2026 adjusted earnings of $9.84B were earned from fewer barrels, not more. Price did the work; the war did the price. Annualising gives ~$39.4B against ~$255B of market cap — ~6.5× — and that number is a trap. ⚠️B
- ROACE has fallen three years running: 12.8% → 11.3% → 9.4%, against a WACC of ~8-10%. Shell reinvests at approximately its cost of capital, which is why management returns half its operating cash flow instead. ✅A
- No published sell-side sum-of-the-parts values Shell's LNG book at an infrastructure multiple — and on the evidence, none should. Cheniere earns ~10.5-13.8× EV/EBITDA on tolling cash flow with a ±3% guidance band; Shell's Integrated Gas segment cash flow went $0.5B → $4.6B in a single quarter and its earnings fell 29.5% in a year. ⛔B — this is the leaf that breaks the thesis
IV. The H-0 thesis — and what happened to it
H-0 (as commissioned): Shell's true operating identity is not "capital-discipline-only harvest major" but "disciplined capital allocator with standing opportunistic-M&A optionality" — and the market's peer-lagging blended multiple prices neither the LNG-platform premium nor the M&A tail that this identity implies.
Mispricing taxonomy as commissioned: structural blindness × category (no sell-side field for an LNG-infrastructure premium), with a secondary cognitive-bias × lifecycle effect (the market anchored on harvest-mode, so ARC registered as a "reversal").
Mispricing taxonomy as found: peak-versus-mid-cycle earnings-base ambiguity. Nobody — including this tree — can currently say what Shell earns in a normal year, because the last three data points are a trough ($18.5B), a war ($9.84B in one quarter), and a segment that printed more in Q2 2026 than it did in the whole of FY2025. That ambiguity, not a template gap, is why the multiple looks strange.
This is a falsifiable system, so here is what the evidence did to the thesis. Four load-bearing premises of the Stage 0-2 scaffold failed R2 against the primary pack and the Q2 print:
| Scaffold premise | What the evidence says |
|---|---|
| FY2025 adjusted earnings are contested at $18.5B vs $23.7B, swinging the multiple 10.5×↔13.4× | Not a contradiction — a year-label error. FY2025 = $18,528M; FY2024 = $23,716M [Tier A]. The multiple is ~13.4×. Shell is less cheap than the bull framing assumed |
| The ARC deal "pushed gearing from 20.7% to 23.2%" | Calendar impossibility. Q1 2026 closed 2026-03-31; ARC was announced 2026-04-27. A 75%-stock deal with a $3.4B cash component was never the cause |
| Gearing is rising toward a constraint; watch for the buyback to slow | Reversed. 23.2% → 18.7%, below the FY2025 level. L1C 1.2 is falsified |
| BP's suspended buyback is the base rate for Shell under leverage stress | Does not transfer. Shell's only 2026 pause (2026-06-12 → 07-14) was UK securities law during the ARC circular, and the full $1.232B was made whole in July. L1C 1.3 is falsified |
And one thing the scaffold does not contain at all: there is a war, and it is the dominant variable in the next twelve months.
The verdict on H-0 is therefore uncomfortable but clear. The identity question is not so much answered as drained. Shell had a windfall quarter, a deleveraged balance sheet and a war-cheapened peer set — the single best natural experiment anyone could design for "standing opportunistic-consolidation readiness" — and it announced a buyback. Meanwhile the structural-blindness leg (L1B 1.2) turns out to run the other way: the market is looking directly at a volatile merchant trading book and declining to pay an infrastructure multiple for it. That is not blindness. That is pricing.
h0 = 39% — partially supported. Read the number correctly: both ✗ leaves are ✗ because the bear premise died, and the loudest ⛔ says the market is right. This is low confidence in the thesis, not a bearish call on the company.
Falsification conditions (revised for what is actually live):
- FF1 — ARC closes and delivers two consecutive quarters of accretive Montney contribution with gearing under 19% → the "disciplined opportunist" reading strengthens.
- FF2 — a formal BP approach materialises → suspend this tree entirely; a transformational merger is a different company (§VIII, RF7).
- FF3 — gearing back above 23% for two consecutive quarters → resurrects the falsified
L1C 1.2. - FF4 — Integrated Gas delivers four consecutive quarters within a ±15% adjusted-earnings band → the infrastructure-multiple claim in
L1B 1.2flips from ⛔ to live. - FF5 — twelve months with no BP event and no further M&A →
L1Ddecays to noise and H-0's optionality leg retires. - FF6 (new, and the one that matters) — two consecutive quarters of adjusted earnings in the $6-7B range, establishing a mid-cycle base. This does not confirm or deny H-0; it makes every other number in this document interpretable for the first time.
V. Tree — five branches
H-0: Shell's real identity is "disciplined allocator with standing M&A optionality,"
and the market prices neither the LNG premium nor the M&A tail.
VERDICT: partially supported, 39% — mostly drained rather than answered.
│
├── L1A — Capital allocation track record ⚠️B partial
│ ├── 1.1 ARC price defensible vs Montney comps ⚠️B partial (comps absent)
│ ├── 1.2 One capital-allocation logic, not two ✅B supported [CRUX w5]
│ └── 1.3 Market's read of the ARC announcement ⊗ not testable (Brent $126 confound)
│
├── L1B — LNG platform premium ⚠️B partial
│ ├── 1.1 LNG scale is real and peer-leading ✅A supported
│ ├── 1.2 LNG deserves an infrastructure multiple ⛔B LEANS AGAINST [CRUX w5]
│ └── 1.3 LNG Canada is a structural growth engine ✅B supported
│
├── L1C — Balance-sheet capacity ✅ premise falsified (good news)
│ ├── 1.1 Shell's stated gearing ceiling ⊗ never published
│ ├── 1.2 Quarters to ceiling at Q1 trajectory ✗A FALSIFIED (23.2% → 18.7%)
│ └── 1.3 BP deleveraging as the base rate ✗B FALSIFIED (pause was legal)
│
├── L1D — BP optionality tail ⚠️B partial
│ ├── 1.1 Flare-up pattern intensity ⚠️B partial (steady, not rising)
│ ├── 1.2 Does the market price any BP probability ⊗ UNMEASURED [CRUX w5]
│ └── 1.3 Execution quality if a deal happened ⚠️B partial (bolt-on ≠ merger)
│
└── L1E — Core segment durability ⚠️B partial
├── 1.1 Upstream on track; ARC incremental ✅B supported (1% → 4% target)
├── 1.2 Marketing + C&P are a stable floor ⛔B LEANS AGAINST (C&P is a trading book)
└── 1.3 Renewables exit without value leakage ⚠️B partial (round-trip unmeasured)
Total: 4 ✅ / 4 ⚠️ / 2 ⛔ / 2 ✗ / 3 ⊗ across 15 leaves
h0 = Σ(weight × value) / Σ(weight) = 14.150 / 36 = 39%
Coverage: 7 of 43 declared weight excluded (16.3%) — below the 1/3 flag threshold,
but one of the three excluded leaves is a CRUX at weight 5 (L1D 1.2).
Full leaf-by-leaf reasoning, evidence and falsification conditions: leaves.md.
VI. Key findings
Finding 1 — The bear case died in a single quarter, and that is bad news for the thesis
Two of the fifteen leaves are marked falsified, and both fail for the same underlying reason: the fact pattern the scaffold was built on stopped being true. Gearing went to 18.7%, the lowest of the three most recent reported points, on $17.5B of quarterly free cash flow. The buyback pause that looked like the beginning of a BP-style capital constraint turned out to be a UK securities-law suspension during the ARC shareholder vote, running exactly 2026-06-12 to 2026-07-14, with the full $1.232B shortfall added back to the July programme.
A thesis needs its question to be live. H-0 asked whether Shell's discipline was cracking or whether cracking was the wrong frame. The honest answer as of August 2026 is that nothing is cracking, which resolves the debate by dissolving it rather than by settling it in either direction.
Finding 2 — The LNG premium is not there, and the reason is instructive
This is the crux leaf and it went the wrong way. mispricing.md argues the market has no valuation field for Shell's LNG trading franchise. Set the two businesses side by side:
| Cheniere Energy | Shell Integrated Gas | |
|---|---|---|
| Model | Tolling — take-or-pay, commodity exposure contracted away | Merchant — equity LNG at realised prices plus a trading book |
| Earnings variance | 2026 adj. EBITDA guided $7.90-8.40B — a ±3% band | Segment AE −29.5% FY2025; segment CFFO $0.5B → $4.6B Q1→Q2 |
| Asset security | US Gulf Coast | ~10% of group production in Qatar, missile-damaged, Q3 guided to zero |
| Multiple | ~10.5-13.8× EV/EBITDA† | inside a blended supermajor multiple |
Infrastructure multiples are compensation for contracted, low-variance, physically-secure cash flow. Shell's LNG segment has kept its commodity exposure — that exposure is where its returns come from — and one-fifth of its production geography was under missile fire this year. A ±3% guidance band and a nine-fold quarterly cash swing do not belong at the same multiple.
The narrow version survives and is worth keeping: LNG Canada specifically (14 Mtpa, Shell 40%, lowest carbon intensity of its class, and the driver of H1 2026 liquefaction being +17%) is genuinely infrastructure-shaped. Nobody has published an SOTP carving that asset, and that remains a real gap — a much smaller one than the thesis claimed.
Finding 3 — Marketing is the best business in the company and nobody talks about it
Buried under the LNG argument sits the one segment with an unambiguously improving trend:
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Adjusted earnings | $3,312M | $3,885M | $3,994M |
| Sales volumes (kboe/d) | 3,045 | 2,843 | 2,753 |
| Cash capex | $5,790M | $2,445M | $1,862M |
Three consecutive years of earnings growth, through the worst commodity collapse in a decade, on falling volumes and a 68% capex cut, with Mobility and Lubricants both at all-time bests. That is a branded-distribution annuity — a retail network, a lubricants brand, a B2B aviation and marine franchise — sitting inside an E&P multiple. It is also the part of Shell most likely to survive a powertrain transition, because a fuel-retail network outlives the fuel.
It is too small to move the group valuation, which is precisely why nobody carves it out. But it is where the durability actually lives.
Finding 4 — Chemicals & Products is not a floor; it is a trading desk with refineries attached
The mirror image, and the reason L1E 1.2 reads ⛔. C&P earned $1.1B in the whole of FY2025, down 65%, against structural European ethylene overcapacity with a further 3 MMTA of closures flagged for 2025-2027. Then in Q2 2026 alone it earned $2.88B — a five-year best — with segment cash flow swinging from −$2.3B to +$7.9B in ninety days.
A segment that earns more in one quarter than in the preceding fiscal year is not a stable floor. It is telling you that its results are dominated by trading and working-capital timing, and both mean-revert. Whatever the correct multiple for Shell is, it should not be computed on a base that includes an un-normalised $2.88B from this segment.
Finding 5 — Shell reinvests at its cost of capital, and management knows it
ROACE: 12.8% → 11.3% → 9.4%. WACC ~8-10%†. The most recent number sits inside the band rather than above it.
This is the structural fact that defines what Shell is. A business that reinvests above its cost of capital compounds; a business that reinvests at its cost of capital creates size. Shell's own capital-allocation policy — 40-50% of CFFO to shareholders, and 52.2% actually distributed in FY2025 — is management stating, in the only language that counts, that they believe the marginal dollar is worth more in a buyback than in the marginal barrel.
On the evidence, they are right. The consequence for the reader is that this is a cash-return position, not a growth position, and it must be sized as one. The 6.5% of shares retired in FY2025 at an average $35.01 is the return; the LNG story is the reason the return is durable.
VII. Three valuation scenarios
(Full construction, including the earnings anchors, in scenarios.md.)
First, the measurement problem, because it dominates everything. Shell's trailing multiple can be made to say almost anything depending on which earnings you divide by:
| Denominator | Adjusted earnings | Implied multiple on ~$255B |
|---|---|---|
| FY2025 actual (trough regime, Brent ~$70-75) | $18,528M | ~13.8× |
| Three-year average FY2023-25 | ~$23,500M | ~10.9× |
| Q2 2026 annualised (war-peak) | ~$39,400M | ~6.5× |
A screen sorting on trailing P/E buys this stock at exactly the wrong moment. The same is true of the peers: XOM at ~26×, CVX at ~34× and BP at ~36× are all trailing multiples on trough earnings, and the "orphan discount" consensus.md sets out to explain is mostly denominator choice, not mispricing.
| Scenario | Prob. | Regime | Earnings basis | Multiple | 12-mo target | Δ from $90.50 |
|---|---|---|---|---|---|---|
| Bull | 25% | War premium persists, Qatar returns, ARC lands clean | $30-34B | 11-12× | $110-120 | +22% to +33% |
| Base | 50% | Gradual de-escalation to $75-85 Brent; mid-cycle | $24-28B | 10-12× | $92-102 | +2% to +13% |
| Bear | 25% | Hormuz reopens, Brent to $60-70, C&P reverts | $17-19B | 11-13× | $70-80 | −23% to −12% |
Note the deliberately inverted multiple bands. The bull case carries the lowest multiple and the bear case the highest. That is not an error — it is how cyclicals are priced, and it is the discipline that stops a ~6.5× peak-earnings P/E from being read as cheapness.
Probability-weighted 12-month return: +6.3%. Probabilities are the K.3.3 default 25/50/25 with no deviation applied; the war widens the dispersion of outcomes but supplies no evidence for skewing them.
Market-implied probabilities (implied_prob.md): 11 / 50 / 39. The market prices roughly 3.5× more bear than bull, and that is largely defensible — Shell printed $9.84B and the stock went from $90.71 to $90.50. The market declined to capitalise the windfall, which is exactly right. My disagreement is 14 percentage points on a zero-excess-return convention; against the sell-side consensus target of ~$100.19 it is closer to five.
Asymmetry 1.59:1 favourable — inside the ordinary band for a large-cap cyclical, and not on its own a reason to own it.
VIII. Triggers and red flags
(Full detail, node linkage and 应对 playbooks in triggers_redflags.md. Every item below references at least one node ID; there are no orphans.)
Checkpoints: CP1 Q3 2026 results ~late Oct · CP2 Q4/FY2026 ~early Feb 2027 · CP3 FY2026 20-F ~Mar 2027 · CP4 Q1 2027 ~May 2027.
Triggers — bull confirmations:
- T2 (CP1→CP4) — Qatar LNG restoration on schedule.
L1B 1.1/1.3L1E 1.1. The highest-torque item in the file: ~10% of group production currently guided to zero, scheduled back by Q1 2027. Confirmation moves probability from bear to base without requiring any view on the oil price. - T1 (H2 2026) — ARC closes.
L1A 1.1/1.2L1E 1.1L1D 1.3. 99.54% holder approval; regulatory pending. A close is the removal of a risk, not the arrival of information — do not add on it. - T3 (CP1+CP2) — two consecutive quarters at $6-7B adjusted earnings.
L1E 1.2L1B 1.2. Settles the denominator question and makes every multiple in this document interpretable for the first time. - T5 (every print) — buyback ≥$3B/quarter with gearing under 19%.
L1C 1.2/1.3L1A 1.2. Track the share count, not the dollar figure — the dollars flatter at a high price. - T4 (undated) — a New York or dual-listing decision.
L1B 1.2, durability Q6. The cleanest re-rating option available: no cash-flow change, potentially a large multiple change. - T6 (undated) — a published SOTP carving LNG Canada or Marketing.
L1B 1.2L1E 1.2. Note: an SOTP marking the whole Integrated Gas segment at an infrastructure multiple is not this trigger, and should be read sceptically per Finding 2.
Red flags — bear confirmations:
- RF6 — an impairment above $2B, or ROACE below 8% for two years.
L1E 1.3L1A 1.2durability Q3. This is the K.3.1 fatal-flag tripwire — it re-cuts capital allocation to 1/5, caps the headline durability at Medium and hard-caps the position at 3% regardless of the 20/25 aggregate. Highest-consequence flag in the file. Most plausible source: the 2027 offshore-wind portfolio sale. - RF3 — Chemicals & Products back below $500M/quarter.
L1E 1.2. The most likely flag to fire, and per Finding 4 the bear case's actual weapon. - RF1 — Brent sustained below $70.
L1E 1.1/1.2L1C 1.2. The Bear scenario's entry condition. Do not add on the multiple looking cheap. - RF2 — Qatar repair slips past Q1 2027.
L1B 1.1/1.3L1E 1.1. The worst configuration available: war-damaged volumes on post-war prices. - RF8 — distributions again above 50% of CFFO while net debt rises.
L1C 1.3, durability Q5. Already fired once — FY2025 distributed 52.2% against a stated 40-50% band. Once is a trough-year overshoot; twice is a policy that does not bind. - RF4 — a buyback tranche cut for cash-flow reasons.
L1C 1.2/1.3. A securities-law pause does not count — that distinction is the entire content ofL1C 1.3. If this fires, exit within 30 days: the distribution is the thesis. - RF5 — gearing above 23% for two consecutive quarters.
L1C 1.2L1C 1.1. The resurrection condition for the falsified leaf. Note 23% is this tree's threshold — Shell has never published one. - RF7 — a BP approach materialises.
L1D 1.1/1.2/1.3. Treated as a red flag, not a trigger. On fire, suspend this tree and rebuild from Stage 1 — a transformational merger is a different company. - RF9 (standing) — currency. See §IX.
IX. Currency and sovereign exposure — mandatory for a non-US domicile
Shell reports in USD. This is the fact that makes SHEL structurally different from every other ADR in this corpus, and it must be stated rather than assumed away.
The conventional ADR framing does not apply here, and applying it would be an error. The reflex for an ADR is "the holder eats a translation drag." For a UK-domiciled company that earns USD revenue against global oil, gas and LNG benchmarks and publishes its accounts in USD, there is no wedge between the reported P&L and the ADS price. Inventing a risk that is not there is the same failure as omitting one that is.
The two-sided statement, and which direction is adverse:
- GBP is close to a non-event, in both directions. A weaker GBP raises the GBp-denominated LSE quote roughly one-for-one while leaving the USD ADS unchanged, and mildly helps Shell by shrinking its UK head-office cost base in USD terms. A stronger GBP does the reverse. The adverse direction is GBP strength, and its magnitude is small — Shell's GBP exposure is a head office and UK staff, not a cost base.
- The channel that actually matters is the broad USD against the commodity complex, and it is material. A strengthening USD is historically associated with softer dollar-denominated commodity prices. That is the adverse direction for a SHEL holder, and it compounds rather than offsets the Bear scenario, because the same dollar strength that compresses Brent compresses Shell's realised prices in its own reporting currency with no translation cushion to absorb it. A weakening USD is the favourable direction.
- A secondary EUR channel runs through European downstream and Chemicals & Products revenue and EUR-denominated debt inside the $75.6B total debt stack. Adverse direction: EUR weakness against USD. Second-order.
Mandatory FX decomposition still applies to every future update_*.md — the four-row table (SHEL.L local return in GBp · GBP/USD translation · implied ADS · actual ADS, residual attributed). For Shell the expected finding is that the FX row is near zero and the local row carries everything. Demonstrating that each quarter is the point: the quarter it stops being true is the quarter something structural has changed.
Sovereign exposure: sovereign-insulated. Running the three questions from dashboards/sovereign_regime_overlay.md §1 in order:
- Where is revenue earned? In USD, globally, against international benchmark prices. UK domestic demand is immaterial to the load-bearing thesis drivers (LNG, upstream, capital return).
- Where are costs and liabilities? Globally distributed; debt is hard-currency and matched to hard-currency revenue. This is the opposite of the historically fatal home-revenue-plus-foreign-debt combination.
- Where does the investor measure returns? In USD — the same currency the business reports in. The wedge is zero.
A UK fiscal or sterling decline is neutral-to-mildly-positive for Shell: the revenue does not move, the UK cost base shrinks in USD terms, and the LSE quote rises to compensate. The analogue in the overlay's §1 table is Ferrari 2011 — a globally-facing business domiciled in a stressed sovereign, re-rating on global rather than sovereign multiples.
The dissent, stated rather than buried. Two channels argue toward sovereign-mixed, and both are real:
- UK regulation is genuinely load-bearing for one branch. The UK Takeover Code governs the entire
L1DBP question — it produced the six-month Rule 2.8 restriction after Shell's June 2025 denial — and UK securities law caused the only buyback interruption of 2026 (the 2026-06-12 to 07-14 ARC-circular pause,L1C 1.3). That is home-country regulatory dependence with a documented, dated effect on the thesis. - A UK-venue multiple discount plausibly exists, and management believes it does. Sawan has publicly reviewed moving the primary listing to New York and the board has explored dual-listing structures, framed explicitly around a valuation gap.
Why the band stays sovereign-insulated anyway. The taxonomy classifies how a home-country economic or fiscal decline transmits to the business. Both dissenting channels are venue and regulatory channels, not economic-transmission channels: a sterling crisis does not invoke the Takeover Code, and the listing discount would be arbitraged by a listing move rather than by a sovereign recovery. Under the overlay's own definitions Shell fails the sovereign-mixed test on the criterion that matters — material home-country demand — decisively. The band describes the business, and this business does not care what happens to the United Kingdom.
X. Long-term holdability verdict
Per durability_test.md: aggregate 20/25 — Medium-High. Zero fatal flags.
| Q | Score | |
|---|---|---|
| Q1 | Business model matters in 10 years | 4/5 — every need persists; liquids face a dated ceiling and NCI is flat at 71 gCO2e/MJ against Shell's own trajectory |
| Q2 | Moat trajectory | 3/5 — LNG Canada and Marketing widening; LNG trading holding with a newly-demonstrated physical failure mode; C&P structurally eroding |
| Q3 | 10-year capital allocation | 3/5 — the weakest question. See below |
| Q4 | Survives disruption | 3/5 — balance sheet passes cleanly; the transition hedge has been sold |
| Q5 | Reinvestment runway above WACC | 3/5 — the runway exists; the returns are approximately WACC |
| Q6 | Upside optionality | 4/5 — NYSE listing, BP tail, Qatar restoration, a partial SOTP |
Four of six questions score exactly 3/5, and that is the finding. This is not a company with a flaw; it is a company without an edge. Nothing here is broken — the balance sheet is excellent, the cost discipline is delivered, the distribution is durable. But 20/25 with zero fatal flags is the profile of a well-run cash-return vehicle, not a compounder, and management's own 40-50%-of-CFFO policy says they agree.
Why the Q3 fatal flag does not fire, stated explicitly rather than assumed. K.3.1 fires on chronic ROIC below WACC or serial value destruction. The case against Shell is substantial — ROACE falling three years running to 9.4%; a renewables round-trip in which capital deployed across 2021-2023 is being exited across 2024-2027 at losses that nobody has aggregated (Atlantic Shores ~$1B written off, Sprng Energy bought at $1.55B and under review, four more wind projects abandoned); and a 66% dividend cut in 2020, the first since the Second World War, inside the ten-year window†. Against it: ROACE was clearly above WACC in FY2023 and FY2024 and sits inside the band in a trough year — cyclical compression, not chronic sub-cost-of-capital operation; the renewables round-trip is one episode under prior strategic direction, now being reversed; and current management has beaten its cost target by three years, absorbed a $16.4B acquisition inside a lowered capex envelope, and sequenced its buyback and its share issuance in the right order.
"Serial" is not established. The flag does not fire — and no other question has been marked up to compensate. But RF6 is the tripwire: one further impairment above $2B, or ROACE below 8% for two years, re-cuts Q3 to 1/5 and fires it.
XI. Position sizing and correlated exposure
K.3 mapping: durability 20/25 (17-21 band) with 0 fatal flags → "selective hold," 1-3%.
- Today: WATCH at 0%. Not held, and no starter authorised. Three of the four things that would make the asymmetry actionable are pending events (Qatar restoration, ARC close, two mid-cycle quarters) and the fourth (the market's pricing of the BP tail) is a crux leaf at weight 5 that has no measurement at all.
- After T2 fires at CP1 (Qatar restoration confirmed on schedule): a 1-2% starter becomes defensible. That single event moves probability from bear to base without requiring a view on the oil price, which is the only kind of catalyst worth pre-positioning for in a commodity name.
- After T3 also fires at CP2 (two consecutive quarters at $6-7B, establishing the mid-cycle base): scale toward 2-3%.
- Hard cap 3% — binding regardless of what happens, because 20/25 is a selective-hold score and because a 3/5 on capital allocation is not a foundation for size.
- Cut to 0% within 30 days if RF4 fires (a buyback cut for cash-flow reasons). For a business scoring 3/5 on reinvestment runway, the distribution is the thesis.
- Suspend the tree entirely if RF7 fires (a BP approach). Rebuild from Stage 1.
Correlated exposure (K.3.4). The load-bearing macro factor is the oil and gas price complex, currently dominated by the Middle East conflict — not the AI-capex cycle.
cycle_exposure: uncorrelated. Shell is first-order independent of hyperscaler capex and does not count toward the K.4 15% correlated-AI bucket. Against a portfolio already heavy in AI-adjacent names (NVDA, TSM, AJNMY, AAPL, GOOGL), SHEL is a genuine diversifier, and that is a real part of its case.- The factor it does share is energy and broad-commodity exposure. No other ticker in the current StockNews corpus is a first-order energy name; the nearest correlates are CAT (industrial capex, partly energy-driven) and F (fuel-price-sensitive demand, in the opposite direction). Combined energy-sleeve cap: 5%.
- The unpriced correlation to name explicitly: SHEL's bull case and the rest of a typical equity portfolio's bull case point in opposite directions. Shell does best when oil is expensive, which is when input costs rise for almost everything else. That makes it a partial hedge — which is an argument for owning some, and an argument against owning much.
- Holder's actual exposure at decision time: NOT RECORDED. The owner does not hold SHEL and no energy-sleeve total was supplied to this build.
XII. Investment Scorecard (per MANUAL_en.md Part K.6)
15-question scorecard (analytical-tree Q-list, Format B per K.3.5)
| # | Question | SHEL answer | Verdict |
|---|---|---|---|
| 1 | What does the company actually do? | UK-domiciled integrated energy major. Five segments: Integrated Gas $8,024M FY2025 AE (LNG liquefaction/shipping/trading, 73 MT/yr ≈ 1/5 of global LNG demand), Upstream ≈$7,400M (~1.4M boe/d), Marketing $3,994M (retail fuels, lubricants, B2B), Chemicals & Products $1,100M, Renewables $172M (exiting). Reports in USD. | ✅A |
| 2 | Why is the stock interesting now? | Q2 2026 adjusted earnings doubled to $9.84B on a war-driven oil price; gearing fell 23.2% → 18.7%; ARC Resources closing H2 2026. But the same war knocked out ~10% of production and Q3 guidance assumes zero Qatar output. Interesting, but not for the reason the headline suggests. | ✅B |
| 3 | Bull case (specific mechanisms)? | (a) War premium persists at $95-110 Brent while Qatar restores in Q1 2027 — price and volume; (b) ARC closes, Montney feeds the LNG platform, production growth target already raised 1% → 4% through 2030; (c) buyback keeps retiring ~6% of the share count a year at accretive prices; (d) an NYSE listing move re-rates the multiple with no cash-flow change. Target $110-120. But (a) requires a war to continue and (d) has been "under review" for over a year. | ⚠️B |
| 4 | Bear case (steelmanned)? | (a) Hormuz reopens, OPEC+ spare capacity returns, Brent to $60-70 — the FY2025 regime in which Shell earned $18.5B and net debt still rose $6.9B; (b) Chemicals & Products reverts: $2.88B in Q2 2026 versus $1.1B in all of FY2025, with segment CFFO swinging −$2.3B → +$7.9B — a working-capital and trading release that reverses; (c) Qatar repair slips past Q1 2027, losing the volume without the price; (d) ROACE at 9.4% and falling means reinvestment creates size, not value; (e) the transition hedge has been sold and NCI is flat at 71. Target $70-80. | ✅B |
| 5 | What valuation is it trading at? | This is the question, and it has no single answer. ~13.8× on FY2025 adjusted earnings; ~10.9× on the three-year average; ~6.5× on annualised Q2 2026. Peer trailing P/Es (XOM ~26×, CVX ~34×, BP ~36×) are computed on trough earnings and are close to uninterpretable as a comparison. The "orphan discount" is mostly denominator choice. | ⚠️B |
| 6 | Is revenue growing? | No. $316,620M (FY2023) → $284,312M (FY2024) → $266,886M (FY2025). Three consecutive years of decline, price-driven rather than share-driven — but a decline is a decline, and this row asks a factual question. | ✗A |
| 7 | Are profits growing? | Mixed, and the direction was reversed by a non-repeatable cause. Adjusted earnings $28,250M → $23,716M → $18,528M (−34.4% over two years), then Q2 2026 at $9.84B versus $4.26B a year earlier. The recovery is a war, not an improvement. | ⚠️A |
| 8 | Is free cash flow positive and growing? | Positive always; not growing through the cycle. FCF $36,457M → $39,533M → $26,052M (FY2025), then $17.5B in Q2 2026 alone / $20.5B H1. Distributions covered 1.16× in FY2025 — adequate, and the tightest in three years. | ⚠️A |
| 9 | Does it have too much debt? | No — and this is the strongest fact in the file. Gearing 18.7%, net debt $41.8B (down $10.8B in one quarter), total debt $75.6B against $42.9B of CFFO in a trough year. Interest paid $4,104M is covered ~10× by trough-year operating cash flow. Survives a 2-3 year demand trough without dilution or distressed financing. | ✅A |
| 10 | Who are the strongest competitors? | ExxonMobil, Chevron, TotalEnergies, BP, ConocoPhillips among the listed majors. More importantly the national oil companies — Saudi Aramco, ADNOC, and QatarEnergy, which is simultaneously Shell's largest LNG partner, its biggest single outage source this year, and its most capable competitor in the same franchise. Shell is a price-taker on molecules. | ⚠️B |
| 11 | What would make me sell? | RF4 (a buyback cut for cash-flow reasons — not a securities-law pause) → exit within 30 days. RF6 (impairment >$2B or ROACE <8% × 2yr) → fires the K.3.1 fatal flag, hard-cap 3%. RF7 (a BP approach) → suspend the tree and rebuild from Stage 1. RF1 + RF3 together → cut to zero. | ✅B |
| 12 | What would prove the thesis wrong? | FF1-FF6 in §IV, revised for what is actually live after R2. Note that FF3 and much of the original bear case are already resolved — L1C 1.2 and L1C 1.3 are both marked falsified. The live one is FF6: two consecutive quarters at $6-7B establishing a mid-cycle base, which does not confirm or deny H-0 but makes every other number here interpretable. | ✅B |
| 13 | Will this business model still matter in 2036? | Yes. Durability Q1 = 4/5. Gas and LNG are the fossil molecules every credible transition pathway keeps longest; Shell sells ~a fifth of global LNG. Liquids plateau inside the window and the NCI is flat at 71 gCO2e/MJ against Shell's own trajectory — the need persists, the product mix has a dated ceiling. | ✅C |
| 14 | Is the moat widening or eroding? Mechanism? | Mixed, and that is the honest answer. WIDENING: LNG Canada (14 Mtpa, drove H1 2026 liquefaction +17%) and Marketing (three straight years of earnings growth on falling volumes and a 68% capex cut). HOLDING with a new failure mode: LNG portfolio trading scale — real and hard to replicate, but ~10% of production was under missile fire this year. NOT A MOAT: Upstream technical capability, directly contestable. ERODING: Chemicals & Products on structural European ethylene overcapacity with 3 MMTA of further closures flagged 2025-2027. | ⚠️B |
| 15 | ROIC > WACC over 10 years? | At the boundary, and trending the wrong way. ROACE 12.8% → 11.3% → 9.4% against a WACC of ~8-10%†. Clearly above in FY2023-24; inside the band in FY2025. The 10-year record also contains a 66% dividend cut in 2020 and a renewables round-trip whose aggregate loss nobody has published. Not chronic sub-WACC operation — which is why the fatal flag does not fire — but not a compounder either. | ⚠️A |
Verdict tally (M1 evidence-tier suffixes per K.3.6): 7 ✅ · 7 ⚠️ · 1 ✗ — Q1✅A, Q2✅B, Q3⚠️B, Q4✅B, Q5⚠️B, Q6✗A, Q7⚠️A, Q8⚠️A, Q9✅A, Q10⚠️B, Q11✅B, Q12✅B, Q13✅C, Q14⚠️B, Q15⚠️A.
(Note on Q4: a ✅ on the bear-case row means the bear case is well-specified and evidenced, not that it will happen. A steelmanned bear case scores well when it is strong, which is the point of asking.)
K.3.5 Weighted-score derivation
Applying the Format B 4-tier mapping from MANUAL §K.3.5 (verdict values: ✅ = 1.0, ⚠️ = 0.5, ✗ = 0.0; ⊗ excluded from numerator and denominator — there are no ⊗ rows here, so the denominator is the full 39):
| Tier | Weight | Rows (verdict) | Verdict-value sum | Weighted contribution |
|---|---|---|---|---|
| Critical (5×) | 5 | Q1 ✅A (does business) · Q9 ✅A (debt — 18.7% gearing) · Q14 ⚠️B (moat MIXED) | 1.0 + 1.0 + 0.5 = 2.5 | 12.5 |
| Load-bearing (3×) | 3 | Q4 ✅B (bear) · Q5 ⚠️B (valuation) · Q11 ✅B (sell-triggers) · Q12 ✅B (falsification) | 1.0 + 0.5 + 1.0 + 1.0 = 3.5 | 10.5 |
| Important (2×) | 2 | Q3 ⚠️B (bull) · Q6 ✗A (revenue) · Q7 ⚠️A (profits) · Q15 ⚠️A (ROIC>WACC) | 0.5 + 0.0 + 0.5 + 0.5 = 1.5 | 3.0 |
| Confirming (1×) | 1 | Q2 ✅B (why now) · Q8 ⚠️A (FCF) · Q10 ⚠️B (competitors) · Q13 ✅C (2036) | 1.0 + 0.5 + 0.5 + 1.0 = 3.0 | 3.0 |
| TOTAL | 29.0 / 39 = 74% |
74% = moderate buy with sizing discipline (65-85% band per K.3.5).
What the score is made of. The two Critical ✅s carry it — Q9 (an 18.7%-geared balance sheet that survives a trough) and Q1 (a business anyone can describe) contribute 10.0 of the 29.0 between them. The damage is concentrated in the Important tier, which contributes only 3.0 of a possible 8.0: revenue has declined three years running (the one ✗), profits fell 34% over two years before a war reversed them, and ROIC sits at the boundary of WACC. That is the arithmetic signature of a high-quality balance sheet attached to a business with no growth and no excess return — which is exactly what the durability test found independently at 20/25 with four questions at 3/5.
The h0 / xii_score gap is 35 points — unusually wide, and it is the single most useful number in this document. xii_score (74%) measures structural quality and finds a well-capitalised, well-run, cash-generative major. h0 (39%) measures thesis confidence and finds an argument about identity and mispricing that the last two months of data have largely dissolved. Shell is a better company than this thesis is a thesis. The correct response to that gap is not to force the thesis — it is to hold the position at zero until an event fires that this tree can actually measure.
K.3.1 precedence check. The fatal-flag override sits above the weighted score. Here it does not bind: zero fatal flags, balance-sheet survivability passes cleanly, and durability at 20/25 is above the 17 threshold. The binding constraint on size is therefore the durability band (17-21 → selective hold, 1-3%), not a flag — but RF6 is one impairment away from changing that.
Scorecard summary
| Dimension | Verdict |
|---|---|
| Company quality | Good, not exceptional — best-in-class balance sheet and cost discipline; no excess return on capital |
| Valuation | Unresolvable at present. 6.5× to 13.8× depending on the earnings base; the base is the open question |
| Growth | Negative on revenue (three straight years); production growth target raised 1% → 4% post-ARC |
| Profitability trajectory | Falling through FY2025, then reversed by a war rather than by the business |
| Cash flow | Strong and durable; $26.1B FCF in a trough year, $17.5B in one war quarter |
| Balance sheet | Excellent — 18.7% gearing, net debt down $10.8B in a quarter, interest covered ~10× at trough |
| Competitive position | Genuine LNG scale leadership; price-taker on molecules; NOCs are partner and competitor at once |
| Long-term durability | 20/25 = Medium-High, 0 fatal flags |
| Risk profile | Commodity cycle · Middle East geopolitics · European chemicals overcapacity · energy-transition terminal value · BP-scale M&A tail |
| Income generation | Dividend $0.3906/quarter growing 4%/yr; buyback retiring ~6% of shares a year — the return is the distribution |
| Recommended stock type | Cyclical / macro-sensitive (K.2) — not a compounder and not a value play; a cash-return vehicle priced on a cycle position nobody can currently locate |
Final verdict: HOLD-WITH-SIZING — WATCH at 0% today; 1-2% starter only after Qatar restoration confirms at CP1; hard cap 3%
For the owner specifically:
- 🔍 Today: 0%. The asymmetry is 1.59:1 — real but ordinary — and three of the four things that would improve it are pending events. There is no penalty for waiting one quarter on a stock whose distribution accrues to whoever owns it later.
- ✅ After T2 (Qatar restoration confirmed on schedule at CP1, ~late Oct 2026): 1-2% starter. This is the only catalyst here that moves probability without requiring an oil-price view.
- ⬆️ After T3 also fires (two quarters at $6-7B, ~Feb 2027): scale to 2-3%.
- 🚫 Hard cap 3%. Binding. A 3/5 on capital allocation is not a foundation for size.
- 🔻 Exit within 30 days if RF4 fires (buyback cut for cash-flow reasons — not a securities-law pause).
- ⛔ Suspend the tree if RF7 fires (a BP approach). Rebuild from Stage 1.
- 📅 Next review 2026-11-05, after Q3 2026 results.
The 2-minute pitch:
"Shell is a well-run oil and gas major that just printed a spectacular quarter for a bad reason. There is a war in the Middle East. Brent went from $70 to a $126 peak, and Shell's adjusted earnings doubled to $9.84B — from fewer barrels, because the same war knocked out its Qatari LNG and Q3 guidance assumes zero output there. Annualise that quarter and Shell trades at 6.5× earnings; use last year's trough and it is 13.8×. Nobody knows the real number, and that ambiguity — not any LNG premium — is why the multiple looks strange. What is genuinely good: gearing fell to 18.7%, net debt down $10.8B in ninety days, cost targets beaten three years early, 6.5% of the shares retired last year at $35 while it just issued stock for ARC Resources at $44.70. What is genuinely mediocre: ROACE has fallen 12.8% → 11.3% → 9.4% against an 8-10% cost of capital, so reinvestment creates size rather than value — which is why management returns half its operating cash flow, and they are right to. Own it for the distribution, not the growth. Wait for the Qatar restoration to confirm in late October, then take 1-2%, cap at 3%. Sell if the buyback gets cut for cash-flow reasons. Walk away entirely if it bids for BP."
Risk types most relevant (per MANUAL_en.md Part K.4):
- Cyclical risk (dominant) — earnings swing with Brent; the current base is war-inflated and the market is right not to capitalise it.
- Regulatory / geopolitical risk — the Strait of Hormuz, the Qatar repair timeline, the UK Takeover Code (which governs the entire L1D branch and caused the only 2026 buyback pause), and the UK Energy Profits Levy on residual North Sea.
- Valuation risk — a trailing P/E that reads 6.5× on peak earnings is the classic cyclical trap; a screen buys this at exactly the wrong moment.
- Execution risk — ARC integration; the 4%-through-2030 production target; the 2027 offshore-wind portfolio sale, which is the most likely source of an RF6 impairment.
- Competition risk — NOCs (Aramco, ADNOC, QatarEnergy) on cost and scale; structural European ethylene overcapacity in Chemicals & Products.
- Currency risk (mandatory for an ADR — see §IX) — not the usual one. Shell reports in USD, so there is no translation wedge. The adverse direction is broad USD strength against the commodity complex, which compresses realised prices in the reporting currency with no cushion.
- Correlated-factor risk — energy-sleeve concentration; but note SHEL is
uncorrelatedto the AI-capex bucket and functions as a partial hedge against the rest of a typical equity portfolio.
"When NOT to buy" anti-pattern check (per MANUAL_en.md Part K.5):
- ❌ People online talking about it — institutional, dividend-investor coverage; no retail-hype signature.
- ⚠️ The stock went up fast — it did not. $90.71 (2026-07-24) → $90.50 (2026-08-11), flat across a doubling of quarterly earnings. The market's refusal to chase is the most reassuring fact in this file.
- ❌ It has "AI" attached — it does not.
cycle_exposure: uncorrelated. - ⚠️ It looks "cheap" — this is the live anti-pattern. At ~6.5× annualised Q2 earnings Shell looks extraordinarily cheap, and that number is the direct product of a missile strike. Every scenario in §VII is built to keep this trap visible, which is why the bull case carries the lowest multiple.
- ❌ You remember the brand — brand familiarity is high (petrol stations) and analytically irrelevant; the analysis is grounded in the FY2025 20-F.
- ❌ "The next [X]" — no pattern-matching claim is made anywhere in this tree.
Net: 2 anti-pattern flags, both on the valuation axis, both pointing the same way — wait for a legible earnings base before paying for a cheap-looking multiple.
XIII. What's NOT in this tree
L1D 1.2— whether the market prices any Shell-BP probability — is a crux leaf at weight 5 and is ⊗. No options skew, no analyst-implied transaction probability, no merger-arb spread was retrievable. This is the highest-value single item for the next refresh, and H-0's second leg cannot be settled without it.- The Q2 2026 print is Tier B throughout.
evidence_2026-08-01.jsonlrows -018 and -019 record that the Stage 0 fetch captured only the 6-K cover wrappers, not the financial exhibits. Every Q2 figure in this document is press aggregation and has not been cross-checked against the primary filing. The largest source-quality weakness in this build. - No Montney transaction comp set (
L1A 1.1) — the ARC premium is known (27%); whether the price was defensible against comparable deals is not. The ARC circular's valuation section should settle it at T1. - The renewables round-trip loss is unmeasured (
L1E 1.3) — capital deployed 2021-2023 versus proceeds realised 2024-2027. Named write-offs clear $1B; nobody has aggregated the total. No estimate was invented. - Shell has published no gearing ceiling (
L1C 1.1, ⊗). The scaffold's "~15-25%" is uncited. RF5's 23% threshold is this tree's, not Shell's. - The ARC announcement's market reaction is not testable (
L1A 1.3, ⊗) — Brent peaked above $126 three days after the announcement. Resolvable only with peer-relative returns for 2026-04-27 → 2026-05-02. mispricing.md's stated mechanism did not survive testing. Stage 1 diagnosed structural blindness × category;L1B 1.2finds the market is pricing, not blind. INDEX_META carries the mechanism as found (peak-vs-mid-cycle-earnings-base-ambiguity), which diverges from the Stage 1 file by design. The Stage 0-2 scaffold files are left unmodified — the divergence is the record of a falsifiable system working.- ADR sponsor unconfirmed —
_watchlist.jsoncarriesadr_sponsor: TBC;primer.mdpresumes BNY Mellon†. The 1:2 ratio is confirmed [Tier A, 20-F 2026-03-12]. - Deferred:
premortem-steelman.md(the Bear scenario carries it),historical-analogue.md,sources.md, andupdate_{YYYY-MM-DD}.md— first scheduled at CP1 (~late Oct 2026), with the mandatory FX decomposition per §IX.
Last updated 2026-08-13 (Stage 3-7 build, Routine C). Source quality: Tier A FY2025 20-F spine; Tier B Q2 2026 print, ARC terms, war/commodity data, all peer multiples. K.3.6 evidence-strength suffixes applied to every leaf and every Section XII row. Next refresh: 2026-11-05, after Q3 2026 results.
"Stories lie, structure doesn't." — 90s.PM.Investing